2025
-
Increased Risk of Skin Cancer in Solid Organ Transplant Recipients Living with HIV.
Hanson M, Zakaria A, Leslie KS. J Am Acad Dermatol. 2025 Jan;92(1):181-183.
-
Immunosuppressive regimens and skin cancer risk in solid-organ transplant recipients
Álvaro Gómez-Tomás, Carlos González-Cruz, Vicente García-Patos and Carla Ferrándiz-Pulido. British Journal of Dermatology Nov 2025
-
Skin cancer in transplant recipients: time to revisit immunosuppression trials?
Commentary on Gomez-Tomas paper Nov 2025 Matthew J Bottomley. British Journal of Dermatology Dec 2025
-
Scottish Consensus Clinical Management Guidelines for Merkel cell cancer
Brendan McCann, Ben Aldridge, Fiona Macdonald, Charlotte Proby, Kaz Rahman, On behalf of the Scottish Merkel Cell Cancer Consensus Group. Journal of Plastic, Reconstructive and Aesthetic Surgery Aug 2025
2024
-
De-escalation of corticosteroids and clonal remission in UBA1mutation-driven VEXAS syndrome with 5-azacytidine.
Trikha R, Kong KL, Galloway J, et al. Haematologica. 2024;109(10):3431-3434.
-
Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients-The High-Risk Balancing Act.
Stump M, Arron S, Proby C. JAMA Dermatol. 2024 Aug 1;160(8):799-800.
-
Cumulative incidence and risk factors for cutaneous squamous-cell carcinoma metastases in organ transplant recipients: the SCOPE-ITSCC metastases study, a prospective multi-center study.
de Jong E, Genders R, Harwood CA, et al. J Am Acad Dermatol. 2024 Jun;90(6):1200-1209.
-
Topical JAK inhibition ameliorates EGFR inhibitor-induced rash in rodents and humans.
You Q, Chen L, Li S, et al. Sci Transl Med. 2024;16(752):eabq7074.
2023
-
How to recognize and manage skin toxicities associated with immune checkpoint inhibitors: a practical approach.
Kawsar A, Hussain K, Fearfield L. Br J Dermatol. 2023;189(Suppl 1):i3-i10.
-
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) for the dermatologist
Sterling D, Duncan ME, Philippidou M, Salisbury JR, Kulasekararaj AG, Basu TN. J Am Acad Dermatol. 2023;89(6):1209-1214.
-
Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study.
Granger EE, Groover M, Harwood C, et al. J Am Acad Dermatol. 2023.
-
Immune Checkpoint Inhibitors in Solid Organ Transplant Recipients With Advanced Skin Cancers-Emerging Strategies for Clinical Management.
Ferrándiz-Pulido C, Leiter U, Harwood C, et al. Transplantation. 2023;107(7):1452-1462.
-
Skin cancer risk in people living with HIV: a call for action.
Reinhart JP, Leslie KS. Lancet HIV. 2024;11(1):e60-e62.
-
External Validation of the Skin and UV Neoplasia Transplant Risk Assessment Calculator (SUNTRAC) in a Large European Solid Organ Transplant Recipient Cohort.
Gómez-Tomás Á, Bouwes Bavinck JN, Genders R, et al. JAMA Dermatol. 2023 Sep 1;159(9):1014.
2022
-
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational study.
Kawsar A, Edwards C, Patel P, et al. Br J Dermatol. 2022;187(6):981-987.
-
Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework
Bottomley MJ, Massey PR, Thuraisingham R, et al. Transpl Int. 2022;35:10880.
-
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU, Ahmed I, Matin RN, et al. . Br J Dermatol. 2022;187(3):324-337.
-
Clinicopathological features, MCPyV status and outcomes of Merkel cell carcinoma in solid-organ transplant recipients: a retrospective, multicentre cohort.
Ferrándiz-Pulido C, Gómez-Tomás A, Llombart B, et al. J Eur Acad Dermatol Venereol. 2022;36(11):1991-2001.
2021
-
The burden of cutaneous disease in solid organ transplant recipients of color
Kentley J, Allawh R, Rao S, et al. Am J Transplant. 2021;21(3):1215-1226.
-
Skin cancer multiplicity in lung transplant recipients: a prospective population-based study
Way M, Marquart L, Chambers DC, et al. Br J Dermatol. 2020;183(3):503-508.
-
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
Galván Casas C, Català A, Carretero Hernández G, et al. Br J Dermatol. 2020;183(1):71-77.
-
Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
Massey PR, Schmults CD, Li SJ, et al. JAMA Dermatol. 2021;157(10):1219-1226. doi:10.1001/jamadermatol.2021.3180
-
Outcome of pretransplant melanoma after solid organ transplantation: an observational study.
Patras M, Decullier E, Lebbé C, et al. Transpl Int. 2021;34(11):2154-2165. doi:10.1111/tri.14109